Bassam Janji

Latest publications

High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia.

  • Tumor Stroma Interactions
  • Tumor Immunotherapy and Microenvironment
May 24, 2018
2018 May. OncoImmunology.7(8):e1465167.
By:
  • Wierz M
  • Janji B
  • Berchem G
  • Moussay E
  • Paggetti J.
Read publication

Inhibition of HIF1alpha-dependent upregulation of Phospho-l-Plastin resensitizes multiple myeloma cells to frontline therapy.

  • Tumor Immunotherapy and Microenvironment
  • Computational Biomedicine
  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
May 23, 2018
2018 May. Int J Mol Sci.19(6):1551.
By:
  • Bosseler M
  • Marani V
  • Broukou A
  • Lequeux A
  • Kaoma T
  • Schlesser V
  • Francois JH
  • Palissot V
  • Berchem GJ
  • Aouali N
  • Janji B.
Read publication

Targeting autophagy in the tumor microenvironment: New challenges and opportunities for regulating tumor immunity.

  • Tumor Immunotherapy and Microenvironment
April 25, 2018
2018 Apr. Front Immunol.9:887.
By:
  • Janji B
  • Berchem G
  • Chouaib S.
Read publication

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target.

  • Tumor Immunotherapy and Microenvironment
  • Tumor Stroma Interactions
April 25, 2018
2018 Apr. OncoImmunology.7(8):e1452583.
By:
  • Noman MZ
  • Paggetti J
  • Moussay E
  • Berchem G
  • Janji B.
Read publication

Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia.

  • Tumor Stroma Interactions
  • Platform National Cytometry
  • Tumor Immunotherapy and Microenvironment
  • NORLUX Neuro-Oncology Laboratory
  • Allergy and Clinical Immunology
April 05, 2018
2018 Apr. Blood.131(14):1617-1621. Epub 2018 Feb 13.
By:
  • Wierz M
  • Pierson S
  • Guyonnet L
  • Viry E
  • Lequeux A
  • Oudin A
  • Niclou SP
  • Ollert M
  • Berchem G
  • Janji B
  • Guerin C
  • Paggetti J
  • Moussay E.
Read publication

Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefield.

  • Tumor Immunotherapy and Microenvironment
March 11, 2018
2018 Mar. Autophagy.14(4):730-732. Epub 2018 Mar 11.
By:
  • Noman MZ
  • Berchem G
  • Janji B.
Read publication

CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.

  • Tumor Immunotherapy and Microenvironment
  • Computational Biomedicine
February 15, 2018
2018 Feb. OncoImmunology.7(4):e1345415.
By:
  • Noman MZ
  • Van Moer K
  • Marani V
  • Gemmill RM
  • Tranchevent LC
  • Azuaje F
  • Muller A
  • Chouaib S
  • Thiery JP
  • Berchem G
  • Janji B.
Read publication

Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.

  • Tumor Immunotherapy and Microenvironment
  • Tumor Stroma Interactions
  • Platform National Cytometry
October 31, 2017
2017 Oct. Proc Natl Acad Sci U S A.114(44):E9271-E9279. Epub 2017 Oct 16.
By:
  • Mgrditchian T
  • Arakelian T
  • Paggetti J
  • Noman MZ
  • Viry E
  • Moussay E
  • Van Moer K
  • Kreis S
  • Guerin C
  • Buart S
  • Robert C
  • Borg C
  • Vielh P
  • Chouaib S
  • Berchem G
  • Janji B.
Read publication

Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.

  • NORLUX Neuro-Oncology Laboratory
  • Computational Biomedicine
  • Platform LUXGEN - Micro-Array
  • Tumor Immunotherapy and Microenvironment
September 05, 2017
2017 Sep. Br J Cancer.117(6):813-825. Epub 2017 Aug 10.
By:
  • Abdul Rahim SA
  • Dirkse A
  • Oudin A
  • Schuster A
  • Bohler J
  • Barthelemy V
  • Muller A
  • Vallar L
  • Janji B
  • Golebiewska A
  • Niclou SP.
Read publication

Human CD56dimCD16dim cells as an individualized Natural Killer cell subset.

  • HIV Clinical and Translational Research
  • Competence Center for Methodology and Statistics
  • Tumor Immunotherapy and Microenvironment
June 19, 2017
2017 Jun. Front Immunol.8:699.
By:
  • Amand M
  • Iserentant G
  • Poli A
  • Sleiman M
  • Fievez V
  • Sanchez IP
  • Sauvageot N
  • Michel T
  • Aouali N
  • Janji B
  • Trujillo-Vargas CM
  • Seguin-Devaux C
  • Zimmer J.
Read publication

Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression.

  • Tumor Immunotherapy and Microenvironment
April 04, 2017
2017 Apr. Oncotarget.8(14):24031-24044.
By:
  • Giuliani M
  • Janji B
  • Berchem G.
Read publication

Cutting edge: NANOG activates autophagy under hypoxic stress by binding to BNIP3L promoter.

  • Tumor Immunotherapy and Microenvironment
February 15, 2017
2017 Feb. J Immunol.198(4):1423-1428. Epub 2017 Jan 16.
By:
  • Hasmim M
  • Janji B
  • Khaled M
  • Noman MZ
  • Louache F
  • Bordereaux D
  • Abderamane A
  • Baud V
  • Mami-Chouaib F
  • Chouaib S.
Read publication

The critical role of hypoxia in tumor-mediated immunosuppression. In Hypoxia and Human Diseases. (Book Chapter)

  • Tumor Immunotherapy and Microenvironment
February 01, 2017
2017 Feb. Zheng J, ed. Intech, 2017. p.349-364. ISBN 978-953-51-2895-3.
By:
  • Aouali N
  • Bosseler M
  • Sauvage D
  • Van Moer K
  • Berchem G
  • Janji B.
Read publication

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.

  • Tumor Immunotherapy and Microenvironment
January 23, 2017
2017 Jan. OncoImmunology.6(1):e1263412.
By:
  • Noman MZ
  • Janji B
  • Abdou A
  • Hasmim M
  • Terry S
  • Tan TZ
  • Mami-Chouaib F
  • Thiery JP
  • Chouaib S.
Read publication

Hijacker of the antitumor immune response: autophagy is showing its worst facet.

  • Tumor Immunotherapy and Microenvironment
  • Tumor Stroma Interactions
November 18, 2016
2016 Nov. Front Oncol.6(246):246.
By:
  • Viry E
  • Noman MZ
  • Arakelian T
  • Lequeux A
  • Chouaib S
  • Berchem G
  • Moussay E
  • Paggetti J
  • Janji B.
Read publication

Renal cell carcinoma programmed death-ligand 1, a new direct target of hypoxia-inducible factor-2 alpha, is regulated by von Hippel-Lindau gene mutation status.

  • Tumor Immunotherapy and Microenvironment
October 01, 2016
2016 Oct. Eur Urol.70(4):623-632. Epub 2015 Dec 23.
By:
  • Messai Y
  • Gad S
  • Noman MZ
  • Le Teuff G
  • Couve S
  • Janji B
  • Kammerer SF
  • Rioux-Leclerc N
  • Hasmim M
  • Ferlicot S
  • Baud V
  • Mejean A
  • Mole DR
  • Richard S
  • Eggermont AM
  • Albiges L
  • Mami-Chouaib F
  • Escudier B
  • Chouaib S.
Read publication

miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.

  • Tumor Immunotherapy and Microenvironment
September 28, 2016
2016 Sep. Cancer Lett.380(1):257-62. Epub 2015 Oct 30.
By:
  • Noman MZ
  • Janji B
  • Berchem G
  • Chouaib S.
Read publication

Role of autophagy in tumor progression and regression. In Targeting autophagy in cancer therapy. (Book Chapter)

  • Tumor Immunotherapy and Microenvironment
September 03, 2016
2016 Sep. Yang J-M, ed. Springer International Publishing, 2016. p.117-131. (Current Cancer Research). ISBN 978-3-319-42740-9.
By:
  • Janji B
  • Chouaib S.
Read publication

The multifaceted role of autophagy in tumor evasion from immune surveillance.

  • Tumor Immunotherapy and Microenvironment
  • Tumor Stroma Interactions
April 05, 2016
2016 Apr. Oncotarget.7(14):17591-607.
By:
  • Janji B
  • Viry E
  • Moussay E
  • Paggetti J
  • Arakelian T
  • Mgrditchian T
  • Messai Y
  • Noman MZ
  • Van Moer K
  • Hasmim M
  • Mami-Chouaib F
  • Berchem G
  • Chouaib S.
Read publication

Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer.

  • Tumor Immunotherapy and Microenvironment
  • Tumor Stroma Interactions
April 01, 2016
2016 Apr. OncoImmunology.5(4):e1062968. Epub 2015 Jun 24.
By:
  • Berchem G
  • Noman MZ
  • Bosseler M
  • Paggetti J
  • Baconnais S
  • Le Cam E
  • Nanbakhsh A
  • Moussay E
  • Mami-Chouaib F
  • Janji B
  • Chouaib S.
Read publication